AstraZeneca PLC
LSE:AZN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
AstraZeneca PLC
LSE:AZN
|
UK |
|
P
|
Parker-Hannifin Corp
SWB:PAR
|
US |
|
G
|
Globe Life Inc
DUS:TMJ
|
US |
|
Mobilezone Holding AG
SIX:MOZN
|
CH |
|
Unilever PLC
F:UNV0
|
UK |
|
R
|
Renault SA
F:RNL1
|
FR |
|
G
|
GoGold Resources Inc
SWB:GGD
|
CA |
|
R
|
Rio Tinto PLC
DUS:RIO1
|
UK |
|
Swastika Investmart Ltd
BSE:530585
|
IN |
|
B
|
Bank of Punjab
KAR:BOP
|
PK |
|
B
|
BCE Inc
NYSE:BCE
|
CA |
|
Ellington Financial Inc
NYSE:EFC
|
US |
|
O
|
Oji Holdings Corp
DUS:OJI
|
JP |
|
Sumitomo Rubber Industries Ltd
TSE:5110
|
JP |
|
R
|
RPM International Inc
SWB:RP8
|
US |
|
H
|
Honda Motor Co Ltd
OTC:HNDAF
|
JP |
|
N
|
Nikon Corp
OTC:NINOY
|
JP |
|
C
|
CITIC Securities Co Ltd
OTC:CIIHY
|
CN |
|
M
|
MGM Resorts International
BMV:MGM
|
US |
|
British American Tobacco plc
LSE:BATS
|
UK |
|
First Quantum Minerals Ltd
TSX:FM
|
CA |
|
Ross Stores Inc
NASDAQ:ROST
|
US |
Bankruptcy Probability
AstraZeneca PLC's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
AstraZeneca PLC Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
194.7B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
651.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
161.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
125.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
GSK plc
XETRA:GS71
|
87.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Sanofi SA
PAR:SAN
|
86B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DE |
|
Bayer AG
XETRA:BAYN
|
49.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
365.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
364.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
226.1B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
AstraZeneca PLC's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, AstraZeneca PLC has total debt of 29B USD. This includes both short-term (2.9B USD) and long-term (26B USD) debt.
You can find a full breakdown on its Balance Sheet.